VX70

VX70 is a humanized monoclonal antibody inhibitor targeting VEGF-A. VX70 can be used for cancers research[1].

12352203

VEGFR

Protein Tyrosine Kinase/RTK

Cancer-Kinase/protease

Cancer

[1]Croy L A, et al. Anti-vegf antibodies and uses thereof. US20130202615A1. 2014-09-16.

Room temperature

Inhibitory Antibodies

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-12900CL1 0.1 mL

Ask

HP209401 200 Reactions

Ask

RG238460 10 µg

Ask

A22026-01 20 µL

Ask

A22026-02 100 μL

Ask

A22026-03 500 μL

Ask